-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation